# Carperitide in Acute Respiratory Distress Syndrome (ARDS)

> **NCT00030121** · PHASE2 · COMPLETED · sponsor: **Suntory Pharmaceutical**

## Conditions studied

- Respiratory Distress Syndrome

## Interventions

- **DRUG:** recombinant human atrial natriuretic polypeptide

## Key facts

- **NCT ID:** NCT00030121
- **Lead sponsor:** Suntory Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-12
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2008-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00030121

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00030121, "Carperitide in Acute Respiratory Distress Syndrome (ARDS)". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00030121. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*